Patents by Inventor Nikunj SHUKLA

Nikunj SHUKLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12091393
    Abstract: Compounds of formulae (I)-(VD): A1-Q-L1-A2-L2-Z??Formula I are useful for enhancing or prolonging an immune response, such as, in a vaccine as an adjuvant or a co-adjuvant.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: September 17, 2024
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Dennis Carson, Mary Patricia Corr, Howard B. Cottam, Tomoko Hayashi, Nikunj Shukla
  • Publication number: 20230365570
    Abstract: The disclosure relates to 1H-pyrazolo[3,4-d]pyrimidin-4-amine compounds and 1-nitro-5-amido-disubstituted furan compounds, or a pharmaceutically acceptable salt thereof, and methods for their use in treating, among other conditions, inflammatory diseases or an autoimmune diseases.
    Type: Application
    Filed: October 5, 2021
    Publication date: November 16, 2023
    Inventors: Dennis A. Carson, Tomoko Hayashi, Mary Patricia Corr, Howard B. cottam, Tadashi Hosoya, Nikunj Shukla
  • Publication number: 20210380546
    Abstract: Compounds useful as an adjuvant, e.g., formulas (I)-(VI) and uses thereof, for example, with immunogenic moieties or other adjuvants, are provided.
    Type: Application
    Filed: October 22, 2019
    Publication date: December 9, 2021
    Inventors: Dennis Carson, Mary Patricia Corr, Howard B. Cottam, Tomoko Hayashi, Nikunj Shukla
  • Patent number: 10471139
    Abstract: Compounds described herein can be used for therapeutic purposes. The compounds can be TLR agonists, such as TLR7 or TLR8 agonists. The compounds can be included in pharmaceutical compositions and used for therapies were being a TLR agonist is useful. The pharmaceutical compositions can include any ingredients, such as carries, diluents, excipients, fillers or the like that are common in pharmaceutical compositions. The compounds can be those illustrated or described herein as well as derivative thereof, prodrug thereof, salt thereof, or stereoisomer thereof, or having any chirality at any chiral center, or tautomer, polymorph, solvate, or combinations thereof. As such, the compounds can be used as adjuvants in vaccines as well as for other therapeutic purposes described herein. The compounds can have any one of the formulae. Examples of the compounds can be reviewed in Table 1 and Table A1 for activates.
    Type: Grant
    Filed: August 15, 2014
    Date of Patent: November 12, 2019
    Assignee: The University of Kansas
    Inventors: Sunil Abraham David, Euna Yoo, Nikunj Shukla, Alex Christopher Salyer, Mallesh Beesu, Subbalakshmi S. Malladi, Cassandra Jones
  • Publication number: 20160166681
    Abstract: Compounds described herein can be used for therapeutic purposes. The compounds can be TLR agonists, such as TLR7 or TLR8 agonists. The compounds can be included in pharmaceutical compositions and used for therapies were being a TLR agonist is useful. The pharmaceutical compositions can include any ingredients, such as carries, diluents, excipients, fillers or the like that are common in pharmaceutical compositions. The compounds can be those illustrated or described herein as well as derivative thereof, prodrug thereof, salt thereof, or stereoisomer thereof, or having any chirality at any chiral center, or tautomer, polymorph, solvate, or combinations thereof. As such, the compounds can be used as adjuvants in vaccines as well as for other therapeutic purposes described herein. The compounds can have any one of the formulae. Examples of the compounds can be reviewed in Table 1 and Table A1 for activates.
    Type: Application
    Filed: August 15, 2014
    Publication date: June 16, 2016
    Inventors: Sunil Abraham DAVID, Euna YOO, Nikunj SHUKLA, Alex Christopher SALYER, Mallesh BEESU, Subbalakshmi, S. MALLADI, Cassandra JONES